Benzinga's Top Upgrades, Downgrades For April 17, 2017

Top Upgrades

  • Wells Fargo upgraded McDonald's Corporation MCD from Market Perform to Outperform. McDonald's shares rose 0.72 percent to $131.70 in pre-market trading.
  • Stifel Nicolaus upgraded Valmont Industries, Inc. VMI from Hold to Buy. Valmont shares fell 1.12 percent to close at $146.30 on Thursday.
  • Raymond James upgraded S&P Global Inc SPGI from Market Perform to Outperform. S&P Global shares fell 0.50 percent to close at $128.28 on Thursday.
  • Analysts at Baird upgraded Knight Transportation KNX from Neutral to Outperform. Knight Transportation shares fell 1.12 percent to close at $31.00 on Thursday.
  • Analysts at Stifel Nicolaus upgraded CIRCOR International, Inc. CIR from Hold to Buy. CIRCOR shares dropped 0.07 percent to close at $56.14 on Thursday.
  • Wells Fargo upgraded Cummins Inc. CMI from Market Perform to Outperform. Cummins shares fell 1.6 percent to close at $144.57 on Thursday.


Top Downgrades

  • Analysts at PiperJaffray downgraded Incyte Corporation INCY from Overweight to Neutral. Incyte shares fell 10.54 percent to $126.00 in pre-market trading.
  • Morgan Stanley downgraded Eli Lilly and Co LLY from Overweight to Equal-Weight. Eli Lilly shares dropped 5.6 percent to $81.11 in pre-market trading.
  • Susquehanna downgraded KLA-Tencor Corp KLAC from Neutral to Negative. KLA-Tencor shares rose 0.13 percent to close at $95.33 on Thursday.
  • Analysts at FBR Capital downgraded Ability Inc ABIL from Outperform to Market Perform. Ability shares closed at $1.21 on Thursday.
  • Analysts at BMO Capital downgraded Eli Lilly and Co LLY from Market Perform to Underperform. Eli Lilly shares dropped 5.6 percent to $81.11 in pre-market trading.
  • Deutsche Bank downgraded Sociedad Quimica y Minera de Chile (ADR) SQM from Buy to Hold. Sociedad Quimica y Minera shares rose 0.03 percent to $37.00 in pre-market trading.


Top Initiations

  • Analysts at BMO Capital initiated coverage on Alnylam Pharmaceuticals, Inc. ALNY with a Outperform rating. The price target for Alnylam Pharmaceuticals is set to $73. Alnylam Pharmaceuticals shares closed at $49.85 on Thursday.
  • Analysts at BMO Capital initiated coverage on Halozyme Therapeutics, Inc. HALO with a Market Perform rating. The price target for Halozyme Therapeutics is set to $14. Halozyme Therapeutics shares closed at $12.81 on Thursday.
  • Analysts at Cowen & Co. initiated coverage on Valeritas Holdings, Inc. VLRX with a Outperform rating. Valeritas shares closed at $6.30 on Thursday.
  • Analysts at Axiom Capital initiated coverage of Canadian Solar Inc. CSIQ with a Buy rating. The price target for Canadian Solar is set to $18. Canadian Solar shares closed at $12.72 on Thursday.
  • Analysts at Macquarie initiated coverage of Himax Technologies, Inc. (ADR) HIMX with a Outperform rating. The price target for Himax Technologies is set to $12. Himax Technologies shares closed at $8.40 on Thursday.
  • Analysts at Goldman Sachs initiated coverage on Integrated Device Technology Inc IDTI with a Neutral rating. The price target for Integrated Device Technology is set to $24. Integrated Device Technology shares closed at $23.24 on Thursday.
  • Analysts at Craig-Hallum initiated coverage on Merit Medical Systems, Inc. MMSI with a Buy rating. The price target for Merit Medical Systems is set to $36. Merit Medical Systems shares closed at $28.20 on Thursday.
Posted In: Consumer DiscretionaryDowngradesInitiationsRestaurantstop upgradesUpgradesDowngradesInitiationAnalyst Ratings